AGM
IMVT icon

Alpine Global Management’s Immunovant IMVT Stock Holding History

Alpine Global Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53M Sell
1,375,000
-1,261,925
-48% -$38.4M 8.61% 1
2026
Q1 		$65.5M Buy
2,636,925
+10,233
+0.4% +$265K 9.81% 1
2025
Q4 		$66.8M Sell
2,626,692
-128,039
-5% -$2.86M 14.39% 1
2025
Q3 		$44.4M Buy
2,754,731
+128,039
+5% +$2.07M 9% 2
2025
Q2 		$42M Hold
2,626,692
– – 9.47% 3
2025
Q1 		$44.9M Buy
2,626,692
+467,788
+22% +$9.79M 11.88% 2
2024
Q4 		$53.5M Buy
2,158,904
+276,200
+15% +$7.83M 15.75% 2
2024
Q3 		$53.7M Sell
1,882,704
-25,000
-1% -$737K 12.99% 1
2024
Q2 		$50.4M Buy
1,907,704
+25,000
+1% +$711K 8.76% 1
2024
Q1 		$60.8M Buy
1,882,704
+484,332
+35% +$17.7M 11.78% 1
2023
Q4 		$58.9M Buy
1,398,372
+145,898
+12% +$5.37M 16.09% 1
2023
Q3 		$48.1M Sell
1,252,474
-187,070
-13% -$4.23M 11.09% 3
2023
Q2 		$27.3M Hold
1,439,544
– – 7.52% 2
2023
Q1 		$22.3M Sell
1,439,544
-60,456
-4% -$1.05M 8.67% 3
2022
Q4 		$26.6M Sell
1,500,000
-2,848,017
-66% -$35.9M 8.85% 2
2022
Q3 		$24.3M Sell
4,348,017
-100,000
-2% -$489K 5.68% 4
2022
Q2 		$17.3M Buy
4,448,017
+586,228
+15% +$2.53M 4.39% 4
2022
Q1 		$21.3M Buy
3,861,789
+854,789
+28% +$5.32M 4.82% 3
2021
Q4 		$25.6M Buy
3,007,000
+6,800
+0.2% +$56.1K 3.77% 1
2021
Q3 		$26.1M Buy
3,000,200
+1,000,200
+50% +$9.02M 5.92% 2
2021
Q2 		$21.1M Buy
2,000,000
+903,022
+82% +$12.6M 2.88% 9
2021
Q1 		$17.6M Buy
+1,096,978
New +$28.9M 1.69% 18

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alpine Global Management's IMVT Position: Q2 2026 in Review

Alpine Global Management reduced its Immunovant (IMVT) stake by 48% in Q2 2026, selling an estimated $38.4M and leaving 1,375,000 shares worth $53M. The position accounts for 8.61% of the portfolio, ranked #1.

Alpine Global Management first reported a position in IMVT in Q1 2021 and has held it in 22 quarters since. The position peaked at $66.8M in Q4 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Alpine Global Management held 1,375,000 shares of Immunovant worth $53M as of Q2 2026.
  • Alpine Global Management sold 1,261,925 Immunovant shares in Q2 2026, an estimated $38.4M.
  • Immunovant made up 8.61% of Alpine Global Management's portfolio in Q2 2026, its #1 holding.
  • Alpine Global Management first reported a position in Immunovant in Q1 2021 and has held it in 22 quarters since.
  • Alpine Global Management's Immunovant position peaked at $66.8M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.